Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02285946
Other study ID # 6032
Secondary ID
Status Recruiting
Phase N/A
First received October 2, 2014
Last updated May 18, 2017
Start date November 2014
Est. completion date September 2017

Study information

Verified date May 2017
Source University Hospital, Strasbourg, France
Contact COLLANGE Olivier, MD
Phone 33369551551
Email olivier.collange@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

During mechanical ventilation, the alveolar recruitment maneuver (ARM) is to apply a positive end-expiratory pressure (PEEP) (generally 30 cm H2O) for a period of at least 30 seconds. The realization of MRA is one of three main elements of mechanical ventilation called "protective". This ventilatory strategy, originally described for the ventilation of acute respiratory distress syndrome (ARDS), and pulmonary and during abdominal surgery is based on a decrease tidal volumes, optimization of PEEP and the realization of MRA. Protective ventilation limit the occurrence of atelectasis, the surdistentions and, ultimately, significantly decreases postoperative complications.

The MRA is currently recommended in the "major" surgery. Most spine surgery (eg transpedicular fixation) used in this definition, the MRA are indicated and now commonly used. This type of surgery requires further positioning the patient in the prone position (DV). The DV modifies the compliance of the chest respiratory characteristics and changes (increase in insufflation pressure) and hemodynamic (decreased venous return) of the patient.

Respiratory and haemodynamic effects of MRA made VIS at major spine surgery are not known. The aim of this observational study, non-interventional, is to compare the hemodynamic and respiratory effects of MRA performed in DV to those of MRA performed in the prone position (DD).

The investigators hypothesis is that the respiratory and hemodynamic consequences of MRA performed in DV is different from those conducted in DD. A better understanding of hemodynamic and respiratory characteristics of MRA performed in DV would provide a more tailored to this type of surgery respiratory optimization strategy and reduce respiratory complications of this surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date September 2017
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Adult patient

Patient operated major spine surgery, including:

- The transpedicular osteotomies

- Tumor spinal surgery (sarcoma, osteosarcoma) or metastatic

- Degenerative spinal surgery on multiple vertebral levels and degraded land

- Surgery of scoliosis

Exclusion Criteria:

- Inability to give informed patient information (eg difficulty of understanding)

- Patient under guardianship - Patient pregnant or during lactation - Detainees or under judicial protection.

- contraindications to MRA: emphysema, pneumothorax, major hypovolemia, hemodynamic instability defined as systolic blood pressure below 90 mmHg or tachycardia greater than 110 bpm.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
major spine surgery


Locations

Country Name City State
France Service D'Anesthesiologie - Nhc Strasbourg
France Service d'Anesthesiologie - NHC Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The hemodynamic and respiratory data are collected before, during and after the completion of 3 ARM (alveolar recruitment maneuver): T1: ARM (in a supine position) (before setting prone position); T2: ARM (prone position) ; T3: ARM at acute respiratory distress syndrome [ARDS] (end of intervention, after supine position); (* At the end of ARM, only hemodynamic data are collected)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03357445 - AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study N/A
Active, not recruiting NCT03396224 - Avenir® Cemented Hip Stem - PMCF